Nasal spray, 0.03% and 0.06%, 10 ml

Respiratory system. Nasal preparations. Decongestants and other topical medications. Sympathomimetics, combinations, excluding corticosteroids. Naphazoline.

ATC code  R01АВ02

• acute rhinitis;
• allergic rhinosinusitis;
• allergic vasomotor rhinitis;
• hyperemia and swelling of mucous membranes of the upper respiratory tract after surgery;
• facilitation of rhinoscopy.

• hypersensitivity to the components of the product;
• closed angle glaucoma;
• severe eye diseases;
• arterial hypertension, tachycardia, pronounced atherosclerosis;
• hyperthyroidism;
• diabetes mellitus;
• chronic rhinitis;
• hypertrophy of the prostate gland;
• concomitant use of monoamine oxidase inhibitors and a period of up to 14 days after the end of their use%
• children under 2 years of age (for Allergozol-DF 0.03%);
• children under 15 years of age (for Allergozol-DF 0.06%).

Precautions for use:

• The product has a resorptive effect, so it should be used for a short time - no more than 1 week, then take a break for a few days.

Drug interactions:

Concomitant use with tricyclic antidepressants may increase the vasoconstrictor effect of naphazoline. Concomitant use of naphazoline with monoamine oxidase inhibitors and for 14 days after its withdrawal may lead to a hypertensive crisis.

The product slows down absorption of local anesthetic agents (prolongs their effect during surface anesthesia).

Intranasally.

0.06% spray for adults and adolescents over 15 years of age:

• 1 injection into each nasal passage 3 times a day.

0.03% spray for children:

• 2 to 6 years of age - 1 injection into each nasal passage 1-2 times a day;
• 6 to 15 years of age - 1 injection into each nasal passage 3 times a day.

The course of treatment is not more than 1 week.

Rare:

• if used for more than 1 week - edema of the mucous membranes, atrophic rhinitis.

Very rare:

• nausea, headache;
• increased blood pressure, tachycardia;
• irritation of the nasal mucosa;
• reactive hyperemia of the nasal mucosa - dry mouth.

Symptoms: decreased body temperature, bradycardia, arterial hypertension, dry mouth, difficulty in breathing, agitation, confusion.

Treatment: withdrawal of the product, symptomatic treatment.

Use of the product during pregnancy and lactation is possible only when the estimated benefit to the mother exceeds the potential risk to the child and fetus.

Approved for children over 2 years of age.

The product has a resorptive effect, so it should be used for a short time - no more than 1 week, then take a break for a few days.

10 ml of the product in polypropylene bottles with a spray lid and a protective cap. One bottle is with instruction for use in Kazakh and Russian language are placed in a carton pack.

Store in a place protected from light, at a temperature below 25°С.

Keep out of the reach of children.

3 years

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan, tel.: (727) 253-03-88.

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan.

Name, address, contact information of the organization accepting claims (proposals) against quality of products from consumers in the territory of the Republic of Kazakhstan, which is responsible for post-authorization safety surveillance of the medicine:

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan,

Tel./Fax: (727) 253-07-07, 253-03-88, e-mail: Адрес электронной почты защищен от спам-ботов. Для просмотра адреса в вашем браузере должен быть включен Javascript.